|
15
|
100
|
2hntF |
Crystallographic structure of human gamma-thrombin |
|
52
|
212
|
2halA |
An episulfide cation (thiiranium ring) trapped in the active site of hav 3c proteinase inactivated by peptide-based ketone inhibitors |
|
59
|
230
|
2hlcA |
Hl collagenase structure at 1.7a resolution |
|
5
|
67
|
2hntC |
Crystallographic structure of human gamma-thrombin |
|
54
|
212
|
2h9hA |
An episulfide cation (thiiranium ring) trapped in the active site of hav 3c proteinase inactivated by peptide-based ketone inhibitors |
|
84
|
306
|
2gz7A |
Structure-based drug design and structural biology study of novel nonpeptide inhibitors of sars-cov main protease |
|
1
|
67
|
2hntE |
Crystallographic structure of human gamma-thrombin |
|
57
|
259
|
2h9tH |
Crystal structure of human alpha-thrombin in complex with suramin |
|
84
|
306
|
2gx4A |
Crystal structure of sars coronavirus 3cl protease inhibitor complex |
|
55
|
198
|
2h5cA |
0.82a resolution crystal structure of alpha-lytic protease at ph 5 |
|
86
|
306
|
2gz8A |
Structure-based drug design and structural biology study of novel nonpeptide inhibitors of sars-cov main protease |
|
89
|
298
|
2gt8A |
Crystal structure of sars coronavirus main peptidase (with an additional ala at the n-terminus of each protomer) in the space group p43212 |
|
60
|
240
|
2h1uA |
Porcine pancreatic elastase complexed with metpheleuglu at ph 5.0 |
|
42
|
183
|
2gvfA |
Hcv ns3-4a protease domain complexed with a macrocyclic ketoamide inhibitor, sch419021 |
|
48
|
185
|
2gkvE |
Crystal structure of the sgpb:p14'-ala32 omtky3-del(1-5) complex |
|
52
|
198
|
2h5dA |
0.9a resolution crystal structure of alpha-lytic protease complexed with a transition state analogue, meosuc-ala-ala-pro-val boronic acid |
|
90
|
305
|
2gt7A |
Crystal structure of sars coronavirus main peptidase at ph 6.0 in the space group p21 |
|
53
|
212
|
2h6mA |
An episulfide cation (thiiranium ring) trapped in the active site of hav 3c proteinase inactivated by peptide-based ketone inhibitors |
|
82
|
306
|
2gz9A |
Structure-based drug design and structural biology study of novel nonpeptide inhibitors of sars-cov main protease |
|
56
|
241
|
2gv6A |
Crystal structure of matriptase with inhibitor cj-730 |
|
30
|
169
|
2ggvB |
Crystal structure of the west nile virus ns2b-ns3 protease, his51ala mutant |
|
88
|
306
|
2h2zA |
Crystal structure of sars-cov main protease with authentic n and c-termini |
|
55
|
241
|
2gv7A |
Structure of matriptase in complex with inhibitor cj-672 |
|
20
|
95
|
2gmtC |
Three-dimensional structure of chymotrypsin inactivated with (2s) n-acetyl-l-alanyl-l-phenylalanyl-chloroethyl ketone: implications for the mechanism of inactivation of serine proteases by chloroketones |
|
61
|
233
|
2h9eH |
Crystal structure of fxa/selectide/napc2 ternary complex |
|
80
|
299
|
2gtbA |
Crystal structure of sars coronavirus main peptidase (with an additional ala at the n-terminus of each protomer) inhibited by an aza-peptide epoxide in the space group p43212 |
|
51
|
223
|
2g81E |
Crystal structure of the bowman-birk inhibitor from vigna unguiculata seeds in complex with beta-trypsin at 1.55 angstrons resolution |
|
16
|
131
|
2gmtB |
Three-dimensional structure of chymotrypsin inactivated with (2s) n-acetyl-l-alanyl-l-phenylalanyl-chloroethyl ketone: implications for the mechanism of inactivation of serine proteases by chloroketones |
|
51
|
243
|
2gddA |
Human beta ii tryptase with inhibitor cra-27592 |
|
18
|
95
|
2gchG |
Refined crystal structure of gamma-chymotrypsin at 1.9 angstroms resolution |
|
54
|
257
|
2gp9B |
Crystal structure of the slow form of thrombin in a self-inhibited conformation |
|
54
|
239
|
2gd4B |
Crystal structure of the antithrombin-s195a factor xa-pentasaccharide complex |
|
59
|
223
|
2g5vA |
Indole-amidine complexes with bovine trypsin |
|
58
|
247
|
2gjgA |
Crystal structure of a pilz-containing protein (pp4397) from pseudomonas putida kt2440 at 2.25 a resolution |
|
15
|
131
|
2gctB |
Structure of gamma-chymotrypsin in the range ph 2.0 to ph 10.5 suggests that gamma-chymotrypsin is a covalent acyl-enzyme adduct at low ph |
|
58
|
256
|
2gdeH |
Thrombin in complex with inhibitor |
|
66
|
240
|
2g4tA |
Anomalous substructure of porcine pancreatic elastase (na) |
|
59
|
223
|
2fx6A |
Bovine trypsin complexed with 2-aminobenzamidazole |
|
55
|
224
|
2g52A |
Anomalous substructure of trypsin (p21) |
|
61
|
234
|
2g00A |
Factor xa in complex with the inhibitor 3-(6-(2'-((dimethylamino)methyl)-4-biphenylyl)-7-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1h-pyrazolo[3,4-c]pyridin-1-yl)benzamide |
|
60
|
223
|
2fx4A |
Bovine trypsin bound by 4-piperidinebutyrate to make acylenzyme complex |
|
41
|
181
|
2fyrA |
Crystal structure of norwalk virus protease grown in the presence of aebsf |
|
15
|
131
|
2gchF |
Refined crystal structure of gamma-chymotrypsin at 1.9 angstroms resolution |
|
60
|
223
|
2g8tA |
Indole-amidine complexes with bovine trypsin |
|
65
|
240
|
2g4uA |
Anomalous substructure of porcine pancreatic elastaase (ca) |
|
49
|
243
|
2fxrA |
Human beta tryptase ii complexed with activated ketone inhibitor cra-29382 |
|
19
|
95
|
2gctC |
Structure of gamma-chymotrypsin in the range ph 2.0 to ph 10.5 suggests that gamma-chymotrypsin is a covalent acyl-enzyme adduct at low ph |
|
58
|
223
|
2g5nA |
Indole-amidine complexes with bovine trypsin |
|
58
|
224
|
2g51A |
Anomalous substructure of trypsin (p1) |
|
39
|
181
|
2fyqA |
Crystal structure of the norwalk virus protease |
